In 2023, the import of composite diagnostic or laboratory reagents to the UAE stood at USD 287.8 million. The forecasted values show a steady increase, with USD 295.1 million expected in 2024, USD 302.52 million in 2025, USD 309.8 million in 2026, USD 316.93 million in 2027, and USD 323.92 million in 2028.
Year-on-year variations demonstrate a consistent upward trend with increasing import values:
- From 2024 to 2025, the growth rate is projected at approximately 2.5%.
- From 2025 to 2026, the growth rate is projected at approximately 2.4%.
- From 2026 to 2027, the growth rate is projected at approximately 2.3%.
- From 2027 to 2028, the growth rate is projected at approximately 2.2%.
The Compound Annual Growth Rate (CAGR) from 2023 to 2028 is around 2.4%, indicating a moderate and steady increase in imports over the forecasted period.
Future trends to watch include advancements in diagnostic technology, changes in healthcare regulations, and shifts in demand due to population health needs. Monitoring global supply chain dynamics and their impact on reagent availability will also be crucial for future forecasting.